|Articles|January 11, 2022
Nitrosamine Control: Understanding the New FDA and EMA Regulations
Author(s)SGS
This technical bulletin discusses major regulatory updates, introduced by the FDA and EMA, regarding nitrosamines and SGS proposed risk assessment method for compliance.
Related Content
Sponsored Content
Trending on Pharmaceutical Technology
1
FDA Activity Round Up – July 2026
2
Midyear 2026 Check-In: AI, Supply Chains, and the NDC-12 Story Nobody's Watching
3
From Predictions to Reality: Mike Stenberg Assesses Pharma Manufacturing's First Half of 2026
4
EMA and EU Innovation Agency Deepen Ties to Speed Up Drug Development
5